[{"data":1,"prerenderedAt":109},["ShallowReactive",2],{"drug-glipizide":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":44,"contraindications":86,"warnings":96,"renal":97,"monitoring":98,"interactions":99,"review":100,"examples":103},"glipizide",1,{"fa":7,"en":8},"گلی‌پیزاید","Glipizide","endocrine",{"fa":11,"en":12},"سولفونیل‌اوره","Sulfonylurea",[14],{"name":15,"market":16},"Glucotrol","US",[18,19,20],"glucotrol","گلیپیزاید","گلی پیزاید",[22,36],{"id":23,"form":24,"route":25,"label":26,"concentration":27,"markets":31,"refs":32},"tab-5","tablet","oral","5 mg tablet",{"amount":28,"unit":29,"perUnit":24,"scored":30},5,"mg",false,[16],[33],{"source":34,"section":35},"fda-glipizide","Package Label",{"id":37,"form":24,"route":25,"label":38,"concentration":39,"markets":41,"refs":42},"tab-10","10 mg tablet",{"amount":40,"unit":29,"perUnit":24,"scored":30},10,[16],[43],{"source":34,"section":35},[45,71],{"id":46,"disease":47,"label":48,"population":51,"type":55,"unit":29,"dose":56,"refs":57,"limits":60,"notes":64},"adult","type-2-diabetes",{"fa":49,"en":50},"دیابت نوع ۲ — شروع ۵ mg قبل از صبحانه","Type 2 diabetes — start 5 mg before breakfast",{"minAge":52},{"value":53,"unit":54},18,"year","fixed",{"perDose":28,"dosesPerDay":5},[58],{"source":34,"section":59},"Dosage and Administration",{"maxPerDay":61,"refs":62},40,[63],{"source":34,"section":59},[65],{"text":66,"refs":69},{"fa":67,"en":68},"سالمند یا بیماری کبد: ۲٫۵ mg. افزایش ۲٫۵ تا ۵ mg؛ حداکثر یک‌باره ۱۵ mg؛ بالاتر منقسم قبل از غذا؛ حداکثر ۴۰ mg\u002Fday.","Elderly or liver disease: 2.5 mg. Increase by 2.5–5 mg; max once-daily 15 mg; higher divided before meals; max 40 mg\u002Fday.",[70],{"source":34,"section":59},{"id":72,"disease":47,"label":73,"population":76,"type":78,"unit":29,"dose":79,"refs":83},"peds",{"fa":74,"en":75},"زیر ۱۸ سال","Under 18 years",{"maxAge":77},{"value":53,"unit":54},"notCalculated",{"reason":80},{"fa":81,"en":82},"بی‌خطری و اثربخشی در کودکان ثابت نشده است.","Safety and effectiveness in children not established.",[84],{"source":34,"section":85},"Pediatric Use",[87],{"id":88,"severity":89,"text":90,"refs":93},"ci","block",{"fa":91,"en":92},"حساسیت؛ دیابت نوع ۱، کتواسیدوز دیابتی.","Hypersensitivity; type 1 diabetes, diabetic ketoacidosis.",[94],{"source":34,"section":95},"Contraindications",[],[],[],[],{"status":101,"reviewer":102,"date":102},"unverified",null,[104],{"regimen":46,"formulation":23,"input":105,"expect":108},{"ageYears":106,"weightKg":107},60,80,{"perDose":28},1792078535857]